CYCLOPHOSPHAMIDE FOR , USP for Diffuse large b-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 12 adverse event reports in the FDA FAERS database where CYCLOPHOSPHAMIDE FOR , USP was used for Diffuse large b-cell lymphoma.
Most Reported Side Effects for CYCLOPHOSPHAMIDE FOR , USP
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 73 | 20.1% | 73 | 1 |
| Neoplasm progression | 62 | 17.1% | 62 | 0 |
| Disease progression | 39 | 10.7% | 6 | 0 |
| Neutropenia | 32 | 8.8% | 21 | 0 |
| Thrombocytopenia | 23 | 6.3% | 22 | 0 |
| Exposure during pregnancy | 21 | 5.8% | 0 | 0 |
| Acute graft versus host disease | 20 | 5.5% | 0 | 0 |
| Leukaemia recurrent | 18 | 5.0% | 18 | 0 |
| Disease recurrence | 16 | 4.4% | 13 | 0 |
| No adverse event | 15 | 4.1% | 0 | 0 |
| Liver function test abnormal | 7 | 1.9% | 0 | 0 |
| Precursor t-lymphoblastic lymphoma/leukaemia recurrent | 6 | 1.7% | 0 | 0 |
| Bacteraemia | 5 | 1.4% | 0 | 0 |
| Chronic graft versus host disease | 5 | 1.4% | 0 | 0 |
| Dehydration | 5 | 1.4% | 0 | 4 |
Other Indications for CYCLOPHOSPHAMIDE FOR , USP
Breast cancer (98)
Acute leukaemia (25)
Prophylaxis against graft versus host disease (25)
Blast crisis in myelogenous leukaemia (21)
Mantle cell lymphoma (21)
Leukaemia (18)
B-cell lymphoma (15)
Plasma cell myeloma (14)
Acute lymphocytic leukaemia (12)
Myelodysplastic syndrome (12)
Other Drugs Used for Diffuse large b-cell lymphoma
RITUXIMAB (22,275)
CYCLOPHOSPHAMIDE (16,598)
DOXORUBICIN (15,213)
VINCRISTINE (14,922)
PREDNISONE (11,266)
LENALIDOMIDE (7,858)
ETOPOSIDE (4,698)
PREDNISOLONE (4,086)
CYTARABINE (3,857)
DEXAMETHASONE (3,696)